During the past decade, Hillcrest Hospital Cancer Center conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 115 clinical trials were completed, i.e. on average, 119.8% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 62 clinical trials were completed. i.e. 159% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hillcrest Hospital Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 90 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Gynecologic Oncology Group" with 28 trials sponsored, "Radiation Therapy Oncology Group" with 20 trials sponsored and "NRG Oncology" with 20 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hillcrest Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 130 trials as a collaborator, "NRG Oncology" with 67 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Hillcrest Hospital Cancer Center" are "Recurrent Ovarian Carcinoma" (24 trials), "Recurrent Fallopian Tube Carcinoma" (19 trials), "Recurrent Primary Peritoneal Carcinoma" (18 trials), "Breast Cancer" (14 trials) and "Ovarian Endometrioid Adenocarcinoma" (14 trials). Many other conditions were trialed in "Hillcrest Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Hillcrest Hospital Cancer Center" are "Drug" (188 trials), "Other" (131 trials), "Biological" (82 trials), "Radiation" (57 trials) and "Procedure" (39 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "Quality-of-Life Assessment" (54 trials), "Paclitaxel" (47 trials), "Carboplatin" (39 trials) and "Cisplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Hillcrest Hospital Cancer Center" are 111 trials for "All" genders, 101 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Hillcrest Hospital Cancer Center". undefined are not yet recruiting, 38 are recruiting, 85 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 86 completed trials in Hillcrest Hospital Cancer Center, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hillcrest Hospital Cancer Center, 11 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".